NASDAQ:IPSC | Profit Breakdown | Century Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2020-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$36.53M-$34.55M
2026-03-31-$23.68M-$21.65M
2025-12-31$0.00-$20.65M-$19.24M-$19.17M
2025-09-30-$36.12M-$34.42M-$34.42M
2025-06-30-$34.66M-$32.54M-$32.54M
2025-03-31$109.16M$74.18M$76.56M$76.56M
2024-12-31$4.17M-$37.28M-$34.3M-$36.07M
2024-09-30$791,000.00-$34.79M-$31.23M-$31.23M
2024-06-30$771,000.00-$34.76M-$31.19M-$31.21M
2024-03-31$855,000.00-$31.31M-$28.06M-$28.06M
2023-12-31$268,000.00-$43.76M-$40.27M-$39.4M
2023-09-30$148,000.00-$35.63M-$32.13M-$32.72M
2023-06-30$99,000.00-$35.08M-$32.34M-$33.29M
2023-03-31$1.72M-$32.08M-$30.06M-$31.26M
2022-12-31$521,000.00-$33.31M-$31.65M-$31.68M
2022-09-30$2.22M-$31.74M-$30.72M-$30.75M
2022-06-30$1.4M-$31.35M-$30.97M-$30.99M
2022-03-31$1.06M-$37.44M-$37.5M-$37.51M
2021-12-31-$27.97M-$28.15M-$28.19M
2021-09-30-$25.83M-$26.01M-$26.01M
2021-06-30-$23.02M-$23.27M-$23.27M
2021-03-31-$18.06M-$18.35M-$18.35M
2020-12-31-$15.26M-$15.53M
2020-09-30-$13.13M-$13.07M
2020-06-30-$15.52M-$15.3M
2020-03-31-$9.67M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31$109.16M-$17.27M-$9.65M-$9.58M
2024-12-31$6.59M-$138.14M-$124.78M-$126.57M
2023-12-31$2.24M-$146.55M-$134.79M-$136.67M
2022-12-31$5.2M-$133.83M-$130.84M-$130.93M
2021-12-31-$94.88M-$95.78M-$95.82M
2020-12-31-$53.9M-$53.58M-$53.58M